Abbott Board Approves Separation of AbbVie, Declares Special Distribution of AbbVie Stock

Abbott (NYSE: ABT ) announced today that its board of directors has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie Inc., and declared a special dividend distribution of all of the outstanding shares of AbbVie common stock. For every 1 share of Abbott common shares held, Abbott shareholders